FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / Articles / Read Article

Print

Bausch + Lomb Seeking to Enter Into New Credit Facilities

Date: Apr 20, 2022 @ 07:00 AM

Bausch Health Companies announced that, in connection with its previously announced intention to separate its eye health business, its wholly owned subsidiary, Bausch + Lomb Corporation, is seeking to enter into a new credit agreement, which is expected to include a $2.5 billion term B loan facility and $500 million revolving facility.

The Term Loan Facility is expected to mature in 2027. The Revolving Credit Facility is expected to mature in 2027 and to be undrawn at closing of the proposed initial public offering ("IPO") of Bausch + Lomb. The Credit Facilities are expected to be secured by substantially all of the assets of Bausch + Lomb and its material, wholly-owned Canadian, U.S., Dutch and Irish subsidiaries, subject to certain exceptions.

Upon completion of the Bausch + Lomb IPO, the proceeds from the Term Loan Facility are expected to be used to fund the repayment of an intercompany note issued to Bausch Health in connection with the Separation.

The foregoing transactions are subject to market and other conditions and are anticipated to close in the second quarter of 2022. However, there can be no assurance that Bausch + Lomb will be able to successfully complete the transactions on the terms described above or at all.

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.